Abstract
The autosomal dominant, giant-platelet disorders1, May-Hegglin anomaly2,3 (MHA; MIM 155100), Fechtner syndrome4 (FTNS; MIM 153640) and Sebastian syndrome5 (SBS), share the triad of thrombocytopenia, large platelets and characteristic leukocyte inclusions (?Döhle-like? bodies). MHA and SBS can be differentiated by subtle ultrastructural leukocyte inclusion features, whereas FTNS is distinguished by the additional Alport-like clinical features of sensorineural deafness, cataracts and nephritis4. The similarities between these platelet disorders and our recent refinement of the MHA (ref. 6) and FTNS (ref. 7) disease loci to an overlapping region of 480 kb on chromosome 22 suggested that all three disorders are allelic. Among the identified candidate genes is the gene encoding nonmuscle myosin heavy chain 9 (MYH9; refs 810), which is expressed in platelets9 and upregulated during granulocyte differentiation10. We identified six MYH9 mutations (one nonsense and five missense) in seven unrelated probands from MHA, SBS and FTNS families. On the basis of molecular modelling, the two mutations affecting the myosin head were predicted to impose electrostatic and conformational changes, whereas the truncating mutation deleted the unique carboxy-terminal tailpiece. The remaining missense mutations, all affecting highly conserved coiled-coil domain positions, imparted destabilizing electrostatic and polar changes. Thus, our results suggest that mutations in MYH9 result in three megakaryocyte/platelet/leukocyte syndromes and are important in the pathogenesis of sensorineural deafness, cataracts and nephritis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mhawech, P. & Saleem, A. Inherited giant platelet disorders. Classification and literature review. Am. J. Clin. Pathol. 113, 176–190 (2000).
Hegglin, R. Gleichzeitige konstitutionelle Veranderungen an Neurtophilen und Thrombocyten . Helv. Med. Acta 12, 439– 440 (1945).
May, R. Leukocyteneinschlusse . Dtsch. Arch. Klin. Med. 96, 1– 6 (1909).
Peterson, L.C., Rao, K.V., Crosson, J.T. & White, J.G. Fechtner syndrome?a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia . Blood 65, 397–406 (1985).
Greinacher, A., Nieuwenhuis, H.K. & White, J.G. Sebastian platelet syndrome: a new variant of hereditary macrothrombocytopenia with leukocyte inclusions. Blut 61, 282–288 (1990).
Martignetti, J.A. et al. The May-Hegglin anomaly (MHA) gene localizes to a <1Mb region on chromosome 22q12.3?13.1. Am. J. Hum. Genet. 66, 1449–1454 (2000).
Cusano, R.,. et al. Localisation of the gene responsible for Fechtner syndrome in a region <600 kb on 22q11-q13. Eur. J. Hum. Genet. (in press).
Saez, C.G., Myers, J.C., Shows, T.B. & Leinwand, L.A. Human nonmuscle myosin heavy chain mRNA: generation of diversity through alternative polyadenylation . Proc. Natl Acad. Sci. USA 87, 1164– 1168 (1990).
Simons, M. et al. Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ. Res. 69, 530–539 (1991).
Toothaker, L.E. et al. Cellular myosin heavy chain in human leukocytes: isolation of 5′ cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation. Blood 78, 1826–1833 (1991).
Kunishima, S. et al. Mapping of a gene for May-Hegglin anomaly to chromosome 22q . Hum. Genet. 105, 379– 383 (1999).
Toren, A. et al. Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11?13 . Am. J. Hum. Genet. 65, 1711– 1717 (1999).
Dunham, I. et al. The DNA sequence of human chromosome 22. Nature 402, 489–495 ( 1999).
Kawamoto, S. & Adelstein, R.S. Chicken nonmuscle myosin heavy chains: differential expression of two mRNAs and evidence for two different polypeptides. J. Cell Biol. 112, 915– 924 (1991).
Lucas, R.C. et al. The isolation and characterization of a cytoskeleton and a contractile apparatus from platelets. in Protides of Biological Fluids (ed. Peeters, H.) 465–470 (Pergamon, New York, 1975).
Noris, P., Spedini, P., Belletti, S., Magrini, U. & Balduini, C.L. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): Clinical and laboratory findings. Am. J. Med. 104, 355– 360 (1998).
Bizzaro, N. L'anomalia di May-Hegglin: una rara causa di piastrinopenia congenita. Descrizione della malattia e di un vasto gruppo familiare del Veneto orientale. Med. Lab. 5, 165–171 ( 1997).
Urato, A.C. & Repke, J.T. May-Hegglin anomaly: a case of vaginal delivery when both mother and fetus are affected. Am. J. Obstet. Gynecol. 179, 260–261 ( 1998).
Moxey-Mims, M.M. et al. End-stage renal disease in two pediatric patients with Fechtner syndrome. Pediatr. Nephrol. 13, 782– 786 (1999).
Sellers, J.R. Myosins: a diverse superfamily. Biochim. Biophys. Acta 1496, 3–22 (2000).
Harrington, W.F. & Rodgers, M.E. Myosin. Annu. Rev. Biochem. 53, 35–73 (1984).
Dominguez, R., Freyzon, Y., Trybus, K.M. & Cohen, C. Crystal structure of a vertebrate smooth muscle myosin motor domain and its complex with the essential light chain: visualization of the pre-power stroke state. Cell 94, 559–571 (1998).
Hodge, T.P., Cross, R. & Kendrick-Jones, J. Role of the COOH-terminal nonhelical tailpiece in the assembly of a vertebrate nonmuscle myosin rod. J. Cell Biol. 118, 1085–1095 (1992).
Citi, S. & Kendrick-Jones, J. Brush border myosin filament assembly and interaction with actin investigated with monoclonal antibodies . J. Muscle Res. Cell Motil. 9, 306– 319 (1988).
Murakami, N., Chauhan, V.P. & Elzinga, M. Two nonmuscle myosin II heavy chain isoforms expressed in rabbit brains: filament forming properties, the effects of phosphorylation by protein kinase C and casein kinase II, and location of the phosphorylation sites. Biochemistry 37, 1989– 2003 (1998).
Crick, F.H.C. The packing of α helices: simple coiled coils. Acta Crystallogr. 6, 685–689 ( 1953).
Willems, P.J. Genetic causes of hearing loss. N. Engl. J. Med. 342 , 1101–1109 (2000).
Lalwani, A.K. et al. A new locus for nonsyndromic hereditary hearing impairment, DFNA17, maps to chromosome 22 and represents a gene for cochleosaccular degeneration . Am. J. Hum. Genet. 64, 318– 323 (1999).
Epstein, C.J. et al. Hereditary macrothromboctopathia, nephritis and deafness. Am. J. Med. 52, 299–310 (1972).
Kelley, M.J., Jawien, W., Ortel, T.L. & Korczak, J.F. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nature Genet. 26, 106–108 (2000).
Acknowledgements
We thank the patients and referring physicians for participation; the ?Fondo Malattie Renali del Bambino? and R. Gusmano for support; and I. Visiers, M. Moxey-Mims and B. Coller for assistance and discussions. This project was supported in part by grants of the Italian Ministry of Health (M. Seri, A.S. & C.L.B.). The Telethon grant E.1313 is gratefully acknowledged (M. Seri). M. Savino is the recipient of a fellowship from the Italian Foundation of Cancer Research (FIRC). R.J.D. was supported in part by grants from the National Institutes of Health, including a Merit Award (5 R37 DK34045), a grant (5 M01 RR00071) for the Mount Sinai General Clinical Research Center and, with J.A.M., a grant (5 P30 HD28822) for the Mount Sinai Child Health Research Center.
Rights and permissions
About this article
Cite this article
Syndrome Consortium, TH. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. Nat Genet 26, 103–105 (2000). https://doi.org/10.1038/79063
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/79063
This article is cited by
-
Platelet desialylation and TFH cells–the novel pathway of immune thrombocytopenia
Experimental Hematology & Oncology (2021)
-
A family with an MYH9-related disorder with different phenotypes masquerading as immune thrombocytopaenia: an underreported disorder in Taiwan
International Journal of Hematology (2020)
-
A new therapeutic target: the CD69-Myl9 system in immune responses
Seminars in Immunopathology (2019)